Mermaid Medical Group announced that the company’s Angel catheter has received European CE Mark approval for the prevention ...

Now that her health has improved, columnist Jolie Lizana's greatest challenge is learning how to live fully within the limits ...

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

The trial will enrol up to 30 PAH and ten ILD-PH class II and III patients for ROC-101 combination therapy.

Biologics represent a breakthrough in the management of airway diseases, offering precision treatments that target specific immune pathways. This special issue, Biologics for Airway Diseases: From ...

Lagos — Shell Nigeria Exploration and Production Company Limited (SNEPCo) and the Nigerian National Petroleum Company Limited (NNPC) last week donated an Endobronchial Ultrasound (EBUS) system and a ...

Congenital diaphragmatic hernia (CDH) remains one of the most challenging neonatal conditions, associated with high morbidity and mortality due to the ...

The ACC issued new guidance for managing common pediatric left-to-right shunts, including ASD, VSD, and PDA, in the ...

Pulmonary embolism, or PE, is a serious and sometimes life-threatening condition that occurs when a blood clot travels to the ...

Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, announces that its CyPath® Lung test will be featured at the ...

Shortness of breath, chronic coughing, or wheezing should not be ignored as they can be signs of a pulmonary condition. A ...